Vaccines for COVID-19: Canada’s vaccine supply

On this page

• Making vaccines available to everyone
• Vaccine distribution
• Forecasted allocation of COVID-19 vaccines

Making vaccines available to everyone

COVID-19 vaccines are available to every eligible person in Canada. There are currently enough mRNA vaccine doses in Canada to meet the needs of the eligible population in accordance with NACI recommendations.

Vaccine supply continues to be managed strategically to best support both Canada's evolving domestic needs and global vaccination efforts.

Canada's vaccine supply includes a central inventory allocated to the provinces and territories and held at their request. It also includes supply to provide provinces and territories with continued access to vaccines for newly eligible populations and for additional doses that may be needed over time.

The vaccine distribution table (updated every Thursday) below describes the quantities of COVID-19 vaccines that have been delivered to provinces and territories.

Vaccine distribution

As of January 20, 2022 there are 7,885,253 COVID-19 vaccine doses in the central vaccine inventory.

Total COVID-19 vaccine confirmed distribution as of January 20, 2022 at 9:00 a.m.

Vaccine distribution	Pfizer/BioNTech Comirnaty	Pfizer/BioNTech Comirnaty (ages 5 - 11)	Moderna SpikeVaxFootnote 1	AstraZeneca	Janssen	Total
Total distributed in Canada	53,719,614	4,377,010	29,058,106	3,067,010	43,800	90,265,540
Newfoundland and Labrador	713,100	68,000	555,224	41,300	250	1,377,874
Prince Edward Island	240,735	19,000	116,380	10,100	500	386,715
Nova Scotia	1,445,382	116,000	705,500	60,860	2,000	2,329,742
New Brunswick	1,141,095	112,000	590,950	61,500	700	1,906,245
Quebec	12,285,453	1,304,000	7,311,726	742,110	100	21,643,389
Ontario	20,469,861	1,614,000	11,323,650	1,174,300	10,000	34,591,811
Manitoba	2,032,590	252,000	1,034,308	92,960	3,250	3,415,108
Saskatchewan	1,919,745	159,000	650,990	108,400	5,000	2,843,135
Alberta	6,610,305	394,000	2,687,654	318,200	10,000	10,020,159
British Columbia	6,812,760	313,000	3,591,220	456,800	11,800	11,185,580
Yukon	8,190	4,000	87,470	20	200	99,880
Northwest Territories	11,700	6,000	91,470	0	0	109,170
Nunavut	15,210	14,000	68,220	0	0	97,430
Federal allocationFootnote 2	13,488	2,010	243,344	460	0	259,302
Footnote 1 Moderna doses reported on the table below are full 100mcg doses. When Moderna vaccine is used as a booster, a half-dose (50mcg) is authorised for use. Return to footnote 1 referrer Footnote 2 Federal allocation includes doses for Public Health Agency of Canada (PHAC), the Canadian Armed Forces, Correctional Service Canada and Global Affairs Canada. Return to footnote 2 referrer

Forecasted allocation of COVID-19 vaccines

Forecasted allocation of COVID-19 vaccines to provinces and territories

Vaccine allocation tables describe the forecasted number of vaccine doses available to provinces and territories, based on newly arriving supply.

Total COVID-19 vaccine allocations as of January 20, 2022 at 9:00 a.m.

Vaccine allocation	Pfizer/BioNTech Comirnaty	Pfizer/BioNTech Comirnaty (ages 5 - 11)	Moderna SpikeVaxFootnote 1
Total allocated in Canada	10,301,850	5,800,000	8,246,180
Newfoundland and Labrador	143,910	68,000	38,000
Prince Edward Island	45,630	24,000	12,100
Nova Scotia	269,100	136,000	72,400
New Brunswick	212,940	112,000	57,600
Quebec	2,310,750	1,304,000	626,900
Ontario	4,095,000	2,152,000	1,080,100
Manitoba	370,890	252,000	100,900
Saskatchewan	311,220	224,000	86,000
Alberta	1,086,930	788,000	323,700
British Columbia	1,411,020	696,000	380,000
Yukon	2,340	8,000	3,700
Northwest Territories	2,340	12,000	3,900
Nunavut	2,340	14,000	3,500
Federal allocationFootnote 2	37,440	10,000	5,457,380
Footnote 1 Moderna doses reported on the table below are full 100mcg doses. When Moderna vaccine is used as a booster, a half-dose (50mcg) is authorised for use. Return to footnote 1 referrer Footnote 2 Federal allocation includes doses for Public Health Agency of Canada (PHAC), the Canadian Armed Forces, Correctional Service Canada and Global Affairs Canada. Return to footnote 2 referrer

Related links

• COVID-19: How provinces and territories make decisions about how, who and when to vaccinate